Alivus Life Sciences Limited: insider trading, SAST and pledges

No insider-trading filing for this company in the last two years.

ReportedPromoterEventLender / detailSharesOf companyTotal encumbered
15 Jul 2024Glenmark Pharmaceuticals Ltd Release (Non-disposal undertaking) Nirma Ltd 9,609,5717.84%7.84%
13 Mar 2024Glenmark Pharmaceuticals Ltd Release — 24,505,43520.00%27.84%
Page 1 of 1

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.